Keynote
Name
Session title
Date
Bio
Plenary Speakers
Andrew R. Frank
Anti-Amyloid Therapies for Alzheimer’s Disease – Arrival in Canada
Date:
Dr. Andrew Frank is a cognitive/behavioural neurologist and researcher at Bruyère Health Memory Clinic at the Élisabeth Bruyère Hospital in Ottawa, Ontario.
After finishing his Bachelor’s degree in Honours Biochemistry at the University of Calgary, Dr. Frank completed his M.D. at the University of British Columbia in Vancouver. He completed his residency in Neurology at the University of Ottawa. Following this, Dr. Frank undertook a subspecialty fellowship in Cognitive and Behavioural Neurology at the Mayo Clinic in Rochester, Minnesota.
Dr. Frank’s clinical practice is focused on the diagnosis and treatment of neurodegenerative diseases, such as dementia due to Alzheimer’s disease. His clinical interest lies in the early detection of cognitive disorders, such as Mild Cognitive Impairment (MCI). As President of the C5R, a national cognitive research network, Dr. Frank’s research interest centers on investigating new pharmacologic treatments and technologies for Alzheimer’s disease.